Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: Reversal of ABCB1-related multidrug resistance by ERK5-IN-1

Fig. 6

Effect of ERK5-IN-1 on the phosphorylation of Akt and Erk1/2. a, KB and KBv200, b, MCF7 and MCF7/adr cells were treated with ERK5-IN-1 at indicated concentrations for 24h. Lapatinib at 10 μM was used as positive control for the blockage of Akt and Erk1/2 phosphorylation. Representative results from three independent experiments were shown in each panel

Back to article page